Evidence map›Paper›PMID 22928974›Full record

ArticleThe Biochemical journal2012

Identification of a novel malonyl-CoA IC(50) for CPT-I: implications for predicting in vivo fatty acid oxidation rates.

Brennan K Smith, Christopher G R Perry, Timothy R Koves, David C Wright, Jeffrey C Smith, P Darrell Neufer, Deborah M Muoio, Graham P Holloway

Abstract readComparative Study
In one paragraph

Article in The Biochemical journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Function (Oxford, England) · 2022
    Article
  7. Article
  8. Review
  9. Exercise Metabolism: Fuels for the Fire.Cold Spring Harbor perspectives in medicine · 2018
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Brennan K SmithDepartment of Human Health and Nutritional Sciences, University of Guelph, Guelph, ON, Canada. smithb@uoguelph.ca
Christopher G R Perry
Timothy R Koves
David C Wright
Jeffrey C Smith
P Darrell Neufer
Deborah M Muoio
Graham P Holloway
University of Guelph · CACarleton University · CA

Funding

TARGETED RESPONSIVE MR AND PET AGENTS FOR B-CELL IMAGINGP01DK058398 · NIDDK · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI MUOIO, DEBORAH M · 2000 to 2016
$26.1M
A Genomic/Metabolomic Strategy to Characterize Cardiac Mitochondrial DysfunctionR01HL101189 · NHLBI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI KELLY, DANIEL PATRICK, MUOIO, DEBORAH M · 2010 to 2013
$2.9M
Mechanisms linking the adipogenic phenotype of aging muscle to insulin resistanceR01AG028930 · NIA · DUKE UNIVERSITY · PI MUOIO, DEBORAH M · 2006 to 2010
$2.0M
Linking Mitochondrial Bioenergetics to Muscle Insulin SensitivityR01DK074825 · NIDDK · EAST CAROLINA UNIVERSITY · PI NEUFER, P DARRELL · 2009 to 2013
$1.6M
Mitochondrial Bioenergetics and Etiology of Insulin ResistanceR01DK073488 · NIDDK · EAST CAROLINA UNIVERSITY · PI NEUFER, P DARRELL · 2007 to 2010
$1.2M
NHLBI NIH HHS HL101189NHLBI NIH HHS R01 HL101189NIA NIH HHS R01 AG028930NIDDK NIH HHS DK074825NIDDK NIH HHS P01 DK058398NIDDK NIH HHS R01 DK073488NIDDK NIH HHS R01 DK074825PHS HHS AK089312
6 · The paper itself

Abstract

Published values regarding the sensitivity (IC(50)) of CPT-I (carnitine palmitoyltransferase I) to M-CoA (malonyl-CoA) inhibition in isolated mitochondria are inconsistent with predicted in vivo rates of fatty acid oxidation. Therefore we have re-examined M-CoA inhibition kinetics under various P-CoA (palmitoyl-CoA) concentrations in both isolated mitochondria and PMFs (permeabilized muscle fibres). PMFs have an 18-fold higher IC(50) (0.61 compared with 0.034 μM) in the presence of 25 μM P-CoA and a 13-fold higher IC(50) (6.3 compared with 0.49 μM) in the presence of 150 μM P-CoA compared with isolated mitochondria. M-CoA inhibition kinetics determined in PMFs predicts that CPT-I activity is inhibited by 33% in resting muscle compared with >95% in isolated mitochondria. Additionally, the ability of M-CoA to inhibit CPT-I appears to be dependent on P-CoA concentration, as the relative inhibitory capacity of M-CoA is decreased with increasing P-CoA concentrations. Altogether, the use of PMFs appears to provide an M-CoA IC(50) that better reflects the predicted in vivo rates of fatty acid oxidation. These findings also demonstrate that the ratio of [P-CoA]/[M-CoA] is critical for regulating CPT-I activity and may partially rectify the in vivo disconnect between M-CoA content and CPT-I flux within the context of exercise and Type 2 diabetes.

Indexed as

AnimalsCarnitineCarnitine O-PalmitoyltransferaseCell Membrane PermeabilityDose-Response Relationship, DrugFatty AcidsInhibitory Concentration 50KineticsMalonyl Coenzyme AMitochondria, MuscleMuscle Fibers, Slow-TwitchMuscle, SkeletalOxidation-ReductionOxygen ConsumptionPalmitoyl Coenzyme APhysical Conditioning, AnimalCarnitineCarnitine O-PalmitoyltransferaseFatty AcidsMalonyl Coenzyme APalmitoyl Coenzyme A

Identifiers

PMID22928974
PMCPMC3863641
OpenAlexW2047818525

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.